Related Experiment Video
Updated: Jun 22, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Mutation of a gene essential for ribosome biogenesis, EMG1, causes Bowen-Conradi syndrome
Joy Armistead1, Sunita Khatkar, Britta Meyer
1Department of Biochemistry and Medical Genetics, University of Manitoba, MB, Canada.
Insights
Bowen-Conradi syndrome (BCS) is caused by a mutation in the EMG1 gene, leading to reduced protein levels and severe developmental issues. This genetic disorder primarily affects the Hutterite population.
Area of Science:
- Genetics and Molecular Biology
- Human Disease Pathogenesis
Background:
- Bowen-Conradi syndrome (BCS) is a severe autosomal-recessive disorder with significant growth impairment and psychomotor retardation, predominantly observed in the Hutterite community.
- Previous research localized the BCS-associated gene to a specific interval on human chromosome 12p13.3.
Purpose of the Study:
- To identify the specific genetic mutation responsible for Bowen-Conradi syndrome (BCS).
- To elucidate the molecular mechanism by which the identified mutation leads to BCS.
Main Methods:
- Candidate gene sequencing within the 1.9 Mbp chromosomal interval linked to BCS.
- Segregation analysis and population screening of the identified variant in Hutterite and non-Hutterite populations.
- Structural modeling, mRNA expression analysis, protein level assessment, and in vitro functional assays (mammalian cell overexpression, yeast two-hybrid).
Main Results:
- A specific variant, c.400A-->G (p.D86G), in the 18S ribosome assembly protein EMG1 gene was identified as the probable cause of BCS.
- The mutation segregated with the disease in affected families and was absent in control populations, indicating its causative role.
- The D86G substitution disrupts a conserved salt bridge, leading to EMG1 protein aggregation, reduced soluble protein levels, and altered protein interactions.
Conclusions:
- The identified mutation in the EMG1 gene is the likely cause of Bowen-Conradi syndrome (BCS).
- The pathogenic mechanism involves protein aggregation due to the mutation, resulting in a functional deficiency of EMG1 protein.
- This finding provides critical insight into the molecular basis of BCS and its impact on early childhood development.
Abstract:
Bowen-Conradi syndrome (BCS) is an autosomal-recessive disorder characterized by severely impaired prenatal and postnatal growth, profound psychomotor retardation, and death in early childhood. Nearly all reported BCS cases have been among Hutterites, with an estimated birth prevalence of 1/355. We previously localized the BCS gene to a 1.9 Mbp interval on human chromosome 12p13.3. The 59 genes in this interval were ranked as candidates for BCS, and 35 of these, including all of the best candidates, were sequenced. We identified variant NM_006331.6:c.400A-->G, p.D86G in the 18S ribosome assembly protein EMG1 as the probable cause of BCS. This mutation segregated with disease, was not found in 414 non-Hutterite alleles, and altered a highly conserved aspartic acid (D) residue. A structural model of human EMG1 suggested that the D86 residue formed a salt bridge with arginine 84 that would be disrupted by the glycine (G) substitution. EMG1 mRNA was detected in all human adult and fetal tissues tested. In BCS patient fibroblasts, EMG1 mRNA levels did not differ from those of normal cells, but EMG1 protein was dramatically reduced in comparison to that of normal controls. In mammalian cells, overexpression of EMG1 harboring the D86G mutation decreased the level of soluble EMG1 protein, and in yeast two-hybrid analysis, the D86G substitution increased interaction between EMG1 subunits. These findings suggested that the D-to-G mutation caused aggregation of EMG1, thereby reducing the level of the protein and causing BCS.
Related Concept Videos
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Pleiotropy
Leaky Scanning
Inborn Errors of Metabolism

